89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,678,746 | -13.0% | 4,966,240 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $88,120,968 | +363.0% | 4,650,183 | +272.1% | 0.00% | +100.0% |
| Q1 2023 | $19,030,983 | +39.8% | 1,249,572 | +16.8% | 0.00% | – |
| Q4 2022 | $13,615,766 | +158.4% | 1,069,581 | +17.5% | 0.00% | – |
| Q3 2022 | $5,269,000 | +210.1% | 910,042 | +72.6% | 0.00% | – |
| Q2 2022 | $1,699,000 | -51.1% | 527,365 | -42.8% | 0.00% | – |
| Q1 2022 | $3,476,000 | -68.8% | 922,230 | +8.3% | 0.00% | – |
| Q4 2021 | $11,133,000 | -22.4% | 851,741 | +16.3% | 0.00% | – |
| Q3 2021 | $14,348,000 | +3.7% | 732,394 | -1.0% | 0.00% | – |
| Q2 2021 | $13,832,000 | -16.7% | 739,603 | +5.4% | 0.00% | – |
| Q1 2021 | $16,611,000 | +3.5% | 701,492 | +6.5% | 0.00% | -100.0% |
| Q4 2020 | $16,056,000 | +43.6% | 658,833 | +51.2% | 0.00% | – |
| Q3 2020 | $11,180,000 | +162.1% | 435,686 | +103.6% | 0.00% | – |
| Q2 2020 | $4,265,000 | -22.4% | 213,977 | -1.7% | 0.00% | – |
| Q1 2020 | $5,498,000 | +14.0% | 217,748 | +18.8% | 0.00% | – |
| Q4 2019 | $4,822,000 | – | 183,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |